Cohera Medical, Inc.® Receives FDA Approval to Begin Clinical Trials of its Sylys® Surgical Sealant in the U.S.
12 juil. 2016 09h30 HE
|
Cohera Medical, Inc.
RALEIGH, N.C., July 12, 2016 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has received...
Carcinoembryonic antigen (CEA) market size worth $2.78 Billion by 2023: Global Market Insights Inc.
16 mai 2016 07h30 HE
|
Global Market Insights, Inc
Dover, DE, May 16, 2016 (GLOBE NEWSWIRE) -- Carcinoembryonic antigen (CEA) market size is forecast to reach USD 2.78 billion by 2023; as reported in the latest study by Global Market Insights,...
New Solutions Decrease Risk of Colorectal Surgical Site Infection
28 nov. 2012 12h00 HE
|
The Joint Commission Center for Transforming Healthcare
OAKBROOK TERRACE, IL--(Marketwire - Nov 28, 2012) - A project to reduce colorectal surgical site infections (SSIs) saved more than $3.7 million in costs for 135 avoided SSIs. The two-and-a-half...
Houston Colon Surgeon Lectured at Annual ASCRS Meeting
26 juin 2012 06h03 HE
|
Colorectal Surgical Associates
HOUSTON, TX--(Marketwire - Jun 26, 2012) - At the annual scientific meeting for the American Society of Colon and Rectal Surgeons (ASCRS), Dr. Eric Haas, a colon and rectal surgeon in Houston,...